Terms: = Sarcomas AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Diagnosis
24 results:
1. [Identification of epithelial-mesenchymal transition markers (emt) by immunohistochemistry in pediatric osteosarcoma and association with clinical outcomes].
Fonseca EV; Olaya N; Patifto EF; Aponte NH; Linares Ballesteros A
Andes Pediatr; 2022 Dec; 93(6):868-877. PubMed ID: 37906804
[TBL] [Abstract] [Full Text] [Related]
2. Long Noncoding RNA PCGEM1 Facilitates Tumor Growth and Metastasis of Osteosarcoma by Sponging miR-433-3p and Targeting OMA1.
Li J; Zhang Y; Sun F; Zhang G; Pan XA; Zhou Q
Orthop Surg; 2023 Apr; 15(4):1060-1071. PubMed ID: 36782343
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical expressions of emt markers in pan-RAS-pERK1/2-positive tumors improve diagnosis and prognosis assessment of non-muscle invasive bladder cancer and muscle invasive bladder cancer patients.
Tripathi K; Maurya N; Goel A; Singhai A; Garg M
Mol Cell Biochem; 2023 Jun; 478(6):1169-1190. PubMed ID: 36239855
[TBL] [Abstract] [Full Text] [Related]
4. Pseudoangiosarcomatous squamous cell carcinoma: a rare subtype of squamous cell carcinoma that needs to be differentiated from angiosarcoma and has a poor prognosis.
Zhan Y; Wan H; Wu L; Ge X; Xie X; Wu L; Cai Y
Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):62-66. PubMed ID: 36227677
[TBL] [Abstract] [Full Text] [Related]
5. Mechanisms, diagnosis and Treatment of Bone Metastases.
Ban J; Fock V; Aryee DNT; Kovar H
Cells; 2021 Oct; 10(11):. PubMed ID: 34831167
[TBL] [Abstract] [Full Text] [Related]
6. Recent Advances in Pathology: the 2021 Annual Review Issue of The Journal of Pathology.
Herrington CS; Poulsom R; Koeppen H; Coates PJ
J Pathol; 2021 Jul; 254(4):303-306. PubMed ID: 34097314
[TBL] [Abstract] [Full Text] [Related]
7. The role of SYT-SSX fusion gene in tumorigenesis of synovial sarcoma.
Feng X; Huang YL; Zhang Z; Wang N; Yao Q; Pang LJ; Li F; Qi Y
Pathol Res Pract; 2021 Jun; 222():153416. PubMed ID: 33848939
[TBL] [Abstract] [Full Text] [Related]
8. LncRNA-TMPO-AS1 promotes apoptosis of osteosarcoma cells by targeting miR-329 and regulating E2F1.
Liu X; Wang H; Tao GL; Chu TB; Wang YX; Liu L
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11006-11015. PubMed ID: 33215415
[TBL] [Abstract] [Full Text] [Related]
9. By targeting TRAF6, miR-140-3p inhibits TGF-β1-induced human osteosarcoma epithelial-to-mesenchymal transition, migration, and invasion.
Guo Q; Zhang N; Liu S; Pang Z; Chen Z
Biotechnol Lett; 2020 Nov; 42(11):2123-2133. PubMed ID: 32562135
[TBL] [Abstract] [Full Text] [Related]
10. miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review.
Guo CM; Liu SQ; Sun MZ
Neoplasma; 2020 Mar; 67(2):215-228. PubMed ID: 31884798
[TBL] [Abstract] [Full Text] [Related]
11. Esophageal Carcinosarcoma with Basaloid Squamous Cell Carcinoma: A Case Report and Review of the Literature.
Ishida H; Fujishima F; Onodera Y; Konno-Kumagai T; Maruyama S; Okamoto H; Sato C; Heishi T; Sakurai T; Taniyama Y; Kamei T; Sasano H
Tohoku J Exp Med; 2019 Dec; 249(4):255-263. PubMed ID: 31852851
[TBL] [Abstract] [Full Text] [Related]
12. Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma.
Wang JY; Yang Y; Ma Y; Wang F; Xue A; Zhu J; Yang H; Chen Q; Chen M; Ye L; Wu H; Zhang Q
Biomed Pharmacother; 2020 Jan; 121():109627. PubMed ID: 31810120
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA-765 targets MTUS1 to promote the progression of osteosarcoma via mediating ERK/emt pathway.
Lv DB; Zhang JY; Gao K; Yu ZH; Sheng WC; Yang G; Gao YZ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4618-4628. PubMed ID: 31210288
[TBL] [Abstract] [Full Text] [Related]
14. Decreased expression of ferritin light chain in osteosarcoma and its correlation with epithelial-mesenchymal transition.
Yu GH; Fu L; Chen J; Wei F; Shi WX
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2580-2587. PubMed ID: 29771443
[TBL] [Abstract] [Full Text] [Related]
15. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
[TBL] [Abstract] [Full Text] [Related]
16. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
Li X; Xu R; Liu H; Fang K
Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
[TBL] [Abstract] [Full Text] [Related]
17. Grade 4 unclassified renal cell carcinoma with sarcomatoid component expressing S-100 protein. A case report with peculiar diagnostic and therapeutic implications.
Miolo G; Ash A; Buonadonna A; Lo Re G; Torrisi E; Cervo S; Santeufemia DA; Tuzi A; Canzonieri V
Cancer Biol Ther; 2014; 15(11):1439-43. PubMed ID: 25482943
[TBL] [Abstract] [Full Text] [Related]
18. Clinical and pathologic analysis of extramedullary tumors after hematopoietic stem cell transplantation.
Huang Q; Reddi D; Chu P; Snyder DS; Weisenburger DD
Hum Pathol; 2014 Dec; 45(12):2404-10. PubMed ID: 25294373
[TBL] [Abstract] [Full Text] [Related]
19. Pathogenesis, diagnosis, and management of cholangiocarcinoma.
Rizvi S; Gores GJ
Gastroenterology; 2013 Dec; 145(6):1215-29. PubMed ID: 24140396
[TBL] [Abstract] [Full Text] [Related]
20. A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples.
Pelosi G; Melotti F; Cavazza A; Rossi G; Maisonneuve P; Graziano P; Barbareschi M; Nakatani Y; Papotti M
Anticancer Res; 2012 Apr; 32(4):1463-73. PubMed ID: 22493387
[TBL] [Abstract] [Full Text] [Related]
[Next]
